« We are delighted to have Pini Ben-Or joining our Advisory Board. Pini will be providing key strategic support to the company executive board. He will bring his 30-year extensive experience in Business and Risk Management Strategy, Analytics and Operations. Importantly, his advice to ensure effective execution of the R&D roadmap, most efficient interdisciplinary collaboration and smooth project management will be of great value to our organization. » Cristina Soviany, CEO Features Analytics
“With its novel and unique eyeDES® AI Surveillance Technology and anomaly detection technique for isolating suspicious incidents of trading patterns, Features Analytics team has made impressive advance in the area of Trading Compliance. It holds a very strong promise if integrated across solutions to address many areas of financial crime. This includes a wide range of use cases covered by the trading transaction monitoring systems, applied to Trading Compliance, AML and Fraud. I am very pleased to support Features Analytics development and growth.“
Pini Ben-Or, a widely recognized international expert and analytics innovator, delivering for the last 30 years technology and risk management solutions to the financial industry, among which acting as Global Head of Analytics at Nice Actimize (2010 – 2018), world leader in financial crime compliance solutions. Since May 2019, Chief Science Officer at Aktana (US).
About Features Analytics
Founded in 2014, Features Analytics has developed eyeDES® - the market only Artificial Intelligence driven detection that identifies any Trading Abuse. Its trade surveillance software applies the principles coming from breakthrough cancer ultrasound AI technology. It measures ‘normal’ market activity and identifies at any moment of time anomalous behavior which indicates potential market abuse. Drastically reduced number of high-quality alerts are generated in pro-active fashion. eyeDES® requires zero rules, zero parameters, no window of time setting. It is also asset class agnostic. Company’s customer engagements include product development agreements with two US Tier 1 investment banks. eyeDES® is in production as of mid 2020.
For more information, please contact Mr. Richard Mener, EVP Corporate Operations - firstname.lastname@example.org.